Avita Medical (RCEL) announced that the board of directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Vance will continue to serve as Chairman of the Board, while board member Jan Stern Reed has been appointed Lead Independent Director. The board intends to engage an executive search firm to assist with selecting a permanent CEO. This process will include a mix of internal and external candidates, including Vance, the company stated.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCEL:
- Avita Medical downgraded to Hold from Buy at Lake Street
- Avita Medical Appoints Cary Vance as Interim CEO
- Avita Medical to be eligible for NTAP reimbursement from CMS for RECELL
- Avita Medical says data shows hospital stay reduction with RCELL System
- Avita Medical Announces $15M Equity Placement Agreement